18F-FDG PET/CT assists the diagnosis of primary pancreatic lymphoma: Two case reports and literature review

18F-FDG PET/CT assists the diagnosis of primary pancreatic lymphoma: Two case reports and literature review

Primary pancreatic lymphoma (PPL) is a rare malignancy, which is defined as a mass centered in pancreas with involvement of contiguous lymph nodes and distant spread may exist. Accurate diagnosis of PPL prior to pathological confirmation remains challenging, underscoring the critical significance of...

Full description

Bibliographic Details
Main Authors:	Jian Wang, Yujing Zhou, Hongwei Liu, Jianli Zhou, Xin Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Medicine
Subjects:	primary pancreatic lymphoma 18F-fluorodeoxyglucose positron emission tomography/computed tomography case report pancreatic carcinoma therapeutic efficacy
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1370762/full

Similar Items

18FDG PET in lymphoma
by: Goldsmith Stanley J.
Published: (2012-01-01)

Advances in the application of 18F-FDG PET/CT radiomics for diagnosis, treatment and prognosis prediction of lymphoma
by: CHENG Ran, et al.
Published: (2023-06-01)

Impact of F-18 Fluorodeoxyglucose PET/CT and PET/MRI on Initial Staging and Changes in Management of Pancreatic Ductal Adenocarcinoma: A Systemic Review and Meta-Analysis
by: Jeong Won Lee, et al.
Published: (2020-11-01)

The 18F-FDG PET scan in oncology
by: T Thientunyakit
Published: (2007-12-01)

Potential Added Value of 18F-FDG PET Metabolic Parameters in Predicting Disease Relapse in Type 1 Autoimmune Pancreatitis
by: Shengxin Chen, et al.
Published: (2024-01-01)

FDG PET/CT and Colonoscopy Combine Synergistically in Colorectal Cancer Primary Diagnosis.
by: Doruk Seyfi, et al.
Published: (2021-06-01)

Is Prone Position [<sup>18</sup>F]FDG PET/CT Useful in Reducing Respiratory Motion Artifacts in Evaluating Hepatic Lesions?
by: Chung Won Lee, et al.
Published: (2023-07-01)

18F-FDG PET/CT in therapy response assessment: oligometastatic colorectal cancer
by: Ibrahim Mansour Nasr, et al.
Published: (2023-02-01)

Influence of [<sup>18</sup>F]FDG-PET/CT on Clinical Management Decisions in Breast Cancer Patients—A PET/CT Registry Study
by: Sebastian Werner, et al.
Published: (2023-07-01)

The Role of Post-treatment FDG-PET/CT Scanning after the First-line Chemotherapy in Predicting Prognosis in Patients with Hodgkin Disease and High-grade Non-Hodgkin Lymphoma: A Comparative Study with Clinical Prognostic Risk Scoring Data
by: Ezgi Başak ERDOĞAN, et al.
Published: (2022-06-01)

Prognostic Implications of 18-FDG Positron Emission Tomography/Computed Tomography in Resectable Pancreatic Cancer
by: Cosimo Sperti, et al.
Published: (2020-07-01)

Diagnostic performance of F-18 FDG PET or PET/CT for detection of recurrent gastric cancer: a systematic review and meta-analysis
by: Chang In Choi, et al.
Published: (2023-11-01)

Relationship of FDG PET/CT Textural Features with the Tumor Microenvironment and Recurrence Risks in Patients with Advanced Gastric Cancers
by: Hyein Ahn, et al.
Published: (2022-08-01)

Exploratory analysis of radiomic as prognostic biomarkers in 18F-FDG PET/CT scan in uterine cervical cancer
by: Nadja Rolim Gonçalves de Alencar, et al.
Published: (2022-12-01)

Preoperative Assessment of Medication-Related Osteonecrosis of the Jaw Using [18F]fluoride Positron Emission Tomography (PET)/CT and [18F]fluorodeoxyglucose PET/MRI in Correlation with Histomorphometry and Micro-CT—A Prospective Comparative Study
by: Christian Philipp Reinert, et al.
Published: (2024-02-01)

Metabolic bulk volume from FDG PET as an independent predictor of progression-free survival in follicular lymphoma
by: Heejune So, et al.
Published: (2023-11-01)

Comparison of diagnostic efficacy of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT in ectopic adrenocorticotropic hormone syndrome
by: Bing Zhang, et al.
Published: (2022-09-01)

Glycolysis on F-18 FDG PET/CT Is Superior to Amino Acid Metabolism on C-11 Methionine PET/CT in Identifying Advanced Renal Cell Carcinoma at Staging
by: Suk-Hyun Lee, et al.
Published: (2021-05-01)

Yield of FDG PET/CT for Defining the Extent of Disease in Patients with Kaposi Sarcoma
by: Louise Pesqué, et al.
Published: (2022-04-01)

18F-FDG PET/CT image findings of a dog with adrenocortical carcinoma
by: Dohee Lee, et al.
Published: (2022-01-01)

Quantification of standardised uptake value for ¹⁸F-FDG positron emission tomography in Malaysia
by: Hanafi, Muhammad Hafiz
Published: (2017)

Disposal of Radioactive Waste Generated at the End of 18F- Fluorodeoxyglucose Production for Positron Emission Tomography - Computed Tomography (PET-CT) Scan at Armed Forces Institute of Radiology and Imaging, Rawalpindi
by: Rizwan Bilal, et al.
Published: (2022-11-01)

A prospective study on dual time 18F-FDG-PET/CT in high-risk prostate cancer patients
by: Mike Allan Mortensen, et al.
Published: (2018-12-01)

Realizing 32-time Scan Duration Reduction of 18F-FDG PET Using Deep Learning Model with Image Augmentation
by: Ali Ghafari, et al.
Published: (2022-08-01)

18F-FDG PET/CT imaging in pulmonary sarcomatoid carcinoma
by: Zhe-Huang Luo, et al.
Published: (2024-02-01)

Predicting the Recurrence of Gastric Cancer Using the Textural Features of Perigastric Adipose Tissue on [<sup>18</sup>F]FDG PET/CT
by: Hyein Ahn, et al.
Published: (2022-10-01)

Primary and Metastatic Brain Tumours Assessed with the Brain and Torso [<sup>18</sup>F]FDG PET/CT Study Protocol—10 Years of Single-Institutional Experiences
by: Agata Pietrzak, et al.
Published: (2021-07-01)

18F-FDG gallbladder uptake: observation from a total-body PET/CT scanner
by: Anna Calabro’, et al.
Published: (2023-01-01)

Relationship of FDG PET/CT imaging features with tumor immune microenvironment and prognosis in colorectal cancer: a retrospective study
by: Jeong Won Lee, et al.
Published: (2024-04-01)

Association Analysis of Maximum Standardized Uptake Values Based on <sup>18</sup>F-FDG PET/CT and EGFR Mutation Status in Lung Adenocarcinoma
by: Jianxiong Gao, et al.
Published: (2023-02-01)

18F-FDG PET/CT radiomics signature and clinical parameters predict progression-free survival in breast cancer patients: A preliminary study
by: Xiaojun Xu, et al.
Published: (2023-03-01)

The role of 18F-FDG PET/CT in patients with synchronous multiple primary malignant neoplasms occurring at the same time
by: Zhe Huang Luo, et al.
Published: (2022-12-01)

Role and Place of PET/CT in the Assessment of Skin Melanoma Prevalence
by: M. V. Sorokina, et al.
Published: (2022-07-01)

Clinical Impact of <sup>18</sup>F-FDG PET/CT in the Diagnostic Workup of Pancreatic Ductal Adenocarcinoma: A Systematic Review
by: Annachiara Arnone, et al.
Published: (2020-12-01)

Relationship between sex hormones levels and 18F-FDG uptake by the ovaries in premenopausal woman
by: Kim Tae Hee, et al.
Published: (2019-09-01)

Evaluation of Age and Sex-Related Metabolic Changes in Healthy Subjects: An Italian Brain 18F-FDG PET Study
by: Michela Allocca, et al.
Published: (2021-10-01)

Amide proton transfer-weighted imaging and stretch-exponential model DWI based 18F-FDG PET/MRI for differentiation of benign and malignant solitary pulmonary lesions
by: Nan Meng, et al.
Published: (2024-03-01)

Predicting Overall Survival with Deep Learning from 18F-FDG PET-CT Images in Patients with Hepatocellular Carcinoma before Liver Transplantation
by: Yung-Chi Lai, et al.
Published: (2023-03-01)

The Relationship Between KRAS Mutation and 18F-FDG Uptake Parameters in Colorectal Cancer
by: Aynur Özen, et al.
Published: (2022-06-01)

Isolated CNS relapse of medullary aggressive high-grade B-cell lymphoma on 18F-FDG-PET/CT
by: Gerard Lambe, et al.
Published: (2022-05-01)